Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression
✍ Scribed by Uta B. Hofmann; Johan R. Westphal; Albert J. W. Zendman; Jürgen C. Becker; Dirk J. Ruiter; Goos N. P. van Muijen
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 626 KB
- Volume
- 191
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Vascular endothelial growth factor (VEGF) is the major endothelial mitogen in central nervous system neoplasms and it is expressed in 64-95% of glioblastomas (GBMs). Tumour cells are the main source of VEGF in GBMs whereas VEGF receptors (VEGFR-1, its soluble form sVEGFR-1, VEGFR-2 and neuropilin-1)
Hepatocyte growth factor/scatter factor (HGF/SF) contributes to the malignant progression of human gliomas. We investigated the effect of HGF/SF on matrix metalloproteinase-2 (MMP-2), membrane type 1 matrix metalloproteinase (MT1-MMP) and tissue inhibitors of metalloproteinases (TIMPs), expressions